Condition: Myopia · Sponsor: Bausch & Lomb Incorporated
A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children
This description comes directly from the study's public registry record.
Yan Zhang · +86 21 60327166 · Yan.Zhang1@bausch.com
Always discuss trial participation with your own doctor first.
| Site 105 | Beijing, Beijing Municipality, China | Active Not Recruiting |
| Site 107 | Dongcheng, Beijing Municipality, China | Active Not Recruiting |
| Site 109 | Xiamen, Fujian, China | Active Not Recruiting |
| Site 111 | Haikou, Hainan, China | Active Not Recruiting |
| Site 110 | Wuhan, Hubei, China | Active Not Recruiting |
| Site 102 | Shanghai, Shanghai Municipality, China | Active Not Recruiting |
| Site 106 | Taiyuan, Shanxi, China | Active Not Recruiting |
| Site 108 | Shenzhen, Shenzhen, China | Active Not Recruiting |
| Site 103 | Chengdu, Sichaun Province, China | Active Not Recruiting |
| Site 104 | Nankai, Tianjin Municipality, China | Active Not Recruiting |
| Site 101 | Wenzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06305663